Monday, December 19, 2016

Medigene eyeing more immunotherapy deals after Bluebird pact

FRANKFURT, Dec 19 (Reuters) - German biotech firm Medigene

said it is drawing more interest from prospective

alliance partners for its technology to boost the immune

response to cancer after its...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)